Anzeige
Mehr »
Mittwoch, 03.06.2026 - Börsentäglich über 12.000 News
UraniumX blickt nach frühem Bohr-Erfolg in eine goldene Zukunft der Atomkraft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von NuWays

ZeitAktuelle NachrichtenRatingLeser
12.03.Solid FY25 results, all eyes on deal flow; chg. est.: DBAG achieved solid FY25 results, meeting NAV/share ...503DBAG released solid FY25 figures, meeting the midpoint of its NAV/share guidance but the higher end of EBITA Fund Investment Services guidance. Deal flow in the short- to mid-term is likely to remain...
► Artikel lesen
11.03.Final FY25 reinforces quality compounder profile, Chg.: ATOSS' FY25 report confirms strong growth with ...731Yesterday's publication of ATOSS' FY25 annual report once again confirmed the exceptional quality of the business model and the structural strengths underpinning its long-term growth story. While the...
► Artikel lesen
11.03.Strong profitability expected, set to overachieve guidance: Multitude is set to overachieve its net ...461Multitude will report its Q4'25 preliminary results tomorrow. Here is what to expect:Q4'25 interest income is expected to fall 7% yoy to €62.8m, driven by Consumer Banking, where interest income is...
► Artikel lesen
10.03.Valuation remains de-coupled from operations: Cantourage's FY24 results meet expectations, alleviating ...664Consolidated FY24 figures finally out - no surprises, sentiment overhang lifted. While the individual financial statements (Einzelabschlüsse) had been available for some time, the delayed publication...
► Artikel lesen
09.03.Clinical growth accelerates, roadmap to scale is clear: Aiforia's H2'25 results showed strong organic ...455Last Friday, Aiforia reported its H2'25 results. Our review in detail:Net sales grew +45% yoy to € 2.1m (vs eNuW +47% yoy)Clinical segment grew +68% yoy to € 1.5m (vs eNuW +70% yoy)The clinical segment...
► Artikel lesen
09.03.KNDS order and USV momentum to power growth, chg.: KNDS APU order, accelerating USV traction and a solid ...582Steyr Motors reported final 2025 results in line with prelims, confirmed its 2026 guidance and provided additional detail on current opportunities with KNDS and in USVs.The KNDS order win improves revenue...
► Artikel lesen
06.03.Turnaround ongoing: first positive adj. EBITDA in history: Global Fashion Group's FY25 report shows clear operational ...775GFG released its FY25 annual report, delivering results that confirm the operational inflection we had been anticipating, rendering the fact that shares still trade at a negative EV unjustified, eNuW.Group...
► Artikel lesen
06.03.GFT Technologies: Momentum improving again, chg.: Prelims indicate growth re-acceleration and AI upside, supporting our ...813GFT's FY'25 prelims indicate improving growth momentum, sequential margin recovery and a clear positioning as an AI enabler, supporting our BUY recommendation.Q4 25 fx-adj. sales grew 7% yoy to € 233m...
► Artikel lesen
06.03.Q4p weak, FY26 guidance mixed; chg. est.: Nabaltec's FY25 results missed estimates, with a weak Q4. ...806Nabaltec published preliminary FY25 figures with a soft end to the year, below our estimates. At the same time, management released a FY26 guidance. While mid single-digit sales growth is expected,...
► Artikel lesen
05.03.Semperit skips 2025 dividend, positioned for FY26 growth: Semperit suspends 2025 dividend, highlighting ...642Yesterday, Semperit disclosed it will suspend a 2025 dividend. In our view, this reflects disciplined capital allocation. In detail: Ahead of its annual results release on March 18th, the company confirmed...
► Artikel lesen
04.03.Nabaltec AG: Earnings Call für Investoren am 30.04.2026: NuWays veranstaltet am 30.04.2026 um 11:00 ...784Die NuWays AG veranstaltet einen Earnings Call mit der Nabaltec AG. Johannes Heckmann (CEO) wird die wichtigsten Highlights aus dem vierten Quartal 2025 der Nabaltec AG erläutern. Unternehmen: Nabaltec...
► Artikel lesen
04.03.Title hopes gone for 25/26 season; Chg.: BVB's exit from UCL and Bundesliga loss dampen earnings outlook, ...730Topic: Within four days BVB got knocked out of the 2025/26 UCL campaign and lost a crucial game in the Bundesliga, which should have put all championship hopes aside. In detail: Last Wednesday, BVB...
► Artikel lesen
03.03.Do&Co: Impact from Middle East conflict looks manageable: Iran-related share price weakness appears overdone ...1.371The 12% sell-off following the escalation around Iran appears disproportionate to DOC's current underlying operational exposure. We therefore view the move as fundamentally unjustified.No direct operational...
► Artikel lesen
03.03.Flughafen Wien: Iran crisis a short-term drag; Q4'25 as expected: Manageable Middle East disruption risk, in-line Q4 ...546A mixed set of developments shapes the near-term picture for Flughafen Wien. The Iran conflict adds uncertainty around passenger growth in 2026, although the direct impact appears manageable at this...
► Artikel lesen
03.03.EPH Group enters Germany with two lakefront projects: EPH plans to enter the German market with two premium ...572EPH announced a principal agreement to acquire two premium hotel developments at lakeside locations in Bavaria, marking the company's planned entry into the German market. The step represents a logical...
► Artikel lesen
27.02.Solid Q4 caps of difficult FY25; Chg.: NFON's FY25 prelim figures exceed expectations, with stable ...499Topic: Yesterday, NFON released a solid set of preliminary FY25 figures, slightly overshooting the latest guidance on the bottom-line. Moreover, management provided an outlook for FY26. In detail:Implied...
► Artikel lesen
27.02.Aiforia: H2'25 preview; accelerating clinical revenue growth expected: For H2'25, sales are seen at € 2.18m ...464Aiforia will report H2'25 results on March 6. Our preview in detail:H2'25 sales look set to increase 47% yoy to € 2.18m (eNuW). Clinical revenue growth is seen to accelerate sequentially (+70% vs +60%...
► Artikel lesen
27.02.OHB: Clear flight path for a structural winner: A structural step-up in European institutional space budgets, ...1.181A structural step-up in institutional space funding by ESA (€ 22.3bn for 2026-28, +32% vs previous budget), the EU (€ 131bn proposed for defence and space 2028-34, several times above the current space...
► Artikel lesen
26.02.Entering UK, unlocking significant growth potential: Westwing enters the UK market, enhancing growth ...601Westwing announced its anticipated entry into the United Kingdom, its 23rd European market and the last major strategic white spot on the company's map. The launch is comprehensive from day one, covering...
► Artikel lesen
26.02.Strengthening mission-critical positioning: Steyr's bolt-on acquisition of BUKH reinforces its position ...607Steyr Motors has announced the acquisition of BUKH, a Denmark-based marine engine specialist, in a strategically clean bolt-on that broadens the offering without diluting Steyr's core identity as a...
► Artikel lesen
25.02.Q1 25/26: Ahead where it matters, waiting on market momentum: Hoenle's Q1 FY 25/26 shows a flat-ish ...718Yesterday, Hoenle released its Q1 (Oct - Dec) figures for FY 25/26 with a stronger than expected bottom-line. In detail: Revenue came in flat-ish yoy at € 21.5m, slightly below expectations (eNuW: €...
► Artikel lesen
25.02.FY25p: Adj. EBITA ahead of expectations, Est. & PT up: INDUS achieved solid FY25 results with sales ... 600On 24th of February 2026, INDUS presented its preliminary full year figures. These indicated a successful FY25, amidst a difficult economic environment. In detail: Q4 sales rose by 6% yoy to € 466.1m...
► Artikel lesen
24.02.Commercial momentum to continue in 2026; Chg. PT: Rosenbauer's strong momentum continues in 2026, driven ...525Rosenbauer recently provided several updates on its commercial activities, indicating continued stronger momentum in 2026. In detail: The first fleet vehicle deployed in Rwanda marked further progress...
► Artikel lesen
23.02.Mixed FY25 prelims // Promising EBITDA guidance for FY26: NAGA reported mixed FY25 prelims as well as ...797NAGA recently reported preliminary FY25 figures that came in as a mixed bag with slightly softer than expected sales but stable OPEX. Further, the company provided a dnew guidance for FY26e. In detail:Sales...
► Artikel lesen
23.02.The odds remain compelling: Multiple compression has created an attractive entry point into ZEAL's ...875Following a multiple compression over the last years (2026e EV/EBITDA c. 37% below 5-year historic median), ZEAL's structural growth profile and earnings trajectory remain intact, creating an attractive...
► Artikel lesen